Trial Profile
International Multicenter Single Blind Randomized Clinical Study to Compare Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgical Procedures Under General Anesthesia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2020
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Remimazolam (Primary) ; Rocuronium bromide (Primary) ; Propofol
- Indications General anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors R-Pharm
- 12 Aug 2020 According to the PAION media release, R-Pharm is currently preparing first market approval dossiers for the licensed territories.
- 06 Nov 2018 According to a R-Pharm media release, the company expects to submit regulatory application with the Ministry of Healthcare of the Russian Federation in Q1 2019.
- 21 Sep 2018 New trial record